Log in

Nano-X Imaging Stock Forecast, Price & News

-2.56 (-9.64 %)
(As of 09/29/2020 12:00 AM ET)
Today's Range
Now: $24.00
50-Day Range N/A
52-Week Range
Now: $24.00
Volume2.06 million shs
Average Volume4.76 million shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend YieldN/A
Nano-X Imaging Ltd. engages in developing and producing X-ray source technology for the medical imaging industry in the United States. It develops novel digital X-ray source, a microelectromechanical system-based semiconductor cathode that achieves electron emission by a non-thermionic low-voltage trigger to nano-scale molybdenum cones. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud software designed to deliver medical screening as a service. Nano-X Imaging Ltd. was incorporated in 2018 and is based in Neve Ilan, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 3.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars

Industry, Sector and Symbol

Industry X-ray apparatus & tubes
Current SymbolNASDAQ:NNOX



Sales & Book Value

Annual SalesN/A



Market Cap$1.07 billion
Next Earnings DateN/A
OptionableNot Optionable
-2.56 (-9.64 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NNOX News and Ratings via Email

Sign-up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Nano-X Imaging (NASDAQ:NNOX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Nano-X Imaging?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nano-X Imaging

What price target have analysts set for NNOX?

3 brokerages have issued 1-year target prices for Nano-X Imaging's stock. Their forecasts range from $65.00 to $70.00. On average, they anticipate Nano-X Imaging's share price to reach $67.50 in the next year. This suggests a possible upside of 181.3% from the stock's current price.
View analysts' price targets for Nano-X Imaging

Who are some of Nano-X Imaging's key competitors?

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nano-X Imaging investors own include Docusign (DOCU), NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Tesla (TSLA), Intel (INTC), Pfizer (PFE), Alibaba Group (BABA), Crowdstrike (CRWD) and JD.Com (JD).

When did Nano-X Imaging IPO?

(NNOX) raised $100 million in an initial public offering on Friday, August 21st 2020. The company issued 5,900,000 shares at $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets served as the underwriters for the IPO and National Securities Corp. was co-manager.

What is Nano-X Imaging's stock symbol?

Nano-X Imaging trades on the NASDAQ under the ticker symbol "NNOX."

How do I buy shares of Nano-X Imaging?

Shares of NNOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nano-X Imaging's stock price today?

One share of NNOX stock can currently be purchased for approximately $24.00.

How big of a company is Nano-X Imaging?

Nano-X Imaging has a market capitalization of $1.07 billion. Nano-X Imaging employs 27 workers across the globe.

What is Nano-X Imaging's official website?

The official website for Nano-X Imaging is www.nanox.vision.

How can I contact Nano-X Imaging?

Nano-X Imaging's mailing address is COMMUNICATIONS CENTER, NEVE ILAN L3, 9085000. The company can be reached via phone at 972-02-995-0506 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.